Bital Savir-Baruch, MD, FACNM

An expert in precision medicine, Dr. Savir focuses on the diagnosis and management of prostate, thyroid and neuroendocrine cancers. Recently, Dr. Savir started a new outpatient clinic to treat patients diagnosed with metastatic castration-resistant prostate cancer with the use of the newest FDA-approved targeted therapy, Pluvicto*.

Dr. Savir is passionate about research having investigator experience in several clinical trials. Her philosophy of care is to provide patients with exceptional service in diagnostic nuclear medicine imaging and radioablation therapy. She emphasizes collaboration among a team of talented nuclear medicine physicians, nuclear radiologists and technologists, nurses and referring physicians to achieve the highest quality of care.

As a clinician, educator and researcher, she has mentored numerous young professionals, including pre-medical and medical students, residents and postgraduate fellows, fostering a commitment to service excellence in the medical field. An active member of nuclear medicine specialty societies such as the SNMMI and ACNM, Dr. Savir holds various leadership positions and contributes significantly to the field. Her research focuses on Nuclear Oncology and Theranostics, with the goal of improving cancer diagnosis and treatment through molecular science and precision medicine.